Sign in
BITRF Stock Price, Chart, Stats & News
Biotron Limited
Save
Biotron Limited (BITRF) does not currently pay a dividend.
–
Market cap
–
Current P/E
–
Forward P/E
BITRF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Biotron Limited is an Australian biotechnology firm focused on the development and market introduction of small-molecule compounds designed to combat various viral infections. The company's primary antiviral agent, BIT225, is currently undergoing Phase II clinical trials to assess its efficacy against SARS-CoV-2, HIV-1, and hepatitis C virus infections. Founded in 1999, Biotron Limited's main offices are situated in Sydney, Australia.
Similar securities
Based on sector and market capitalization
Report issue